Skip to main content
. Author manuscript; available in PMC: 2019 May 25.
Published in final edited form as: Oncogene. 2016 Sep 19;36(10):1430–1439. doi: 10.1038/onc.2016.311

Figure 2. INO80 is required for lung cancer cells growth in vitro.

Figure 2.

(A) Growth curves showing the impact of Ino80 silencing on lung cancer cell lines. Lung cancer cells were infected with lentiviral-based non-targeting (shNT) or Ino80 shRNA (shIno80) viruses and cell growth was determined at the indicated time points. Data was plotted as Mean ± SEM from 3 independent experiments. (B-C) Clonogenesis assay for NSCLC cells infected with NT (shNT), Ino80-shRNA (shIno80), or Ino80 shRNA-2 (shIno80–2) viruses. (B) Representative images. (C) Statistical analysis for A549 cells. (D-E) Anchorage-independent growth of NSCLC cells. H23 cells were not included as they did not form colonies in soft-agar. (D) Representative images. (E) Statistical analysis for A549 cells.